Device Dossier

Acquired genetic alteration IVDs

Device Dossier for Acquired genetic alteration IVDs (CT929 - Acquired genetic alteration IVDs, Class 3, sponsor Qiagen). ARTG record, intended purpose,…

Intended purpose

IVDs intended for the detection of somatic mutations in oncogenes using nucleic acids extracted from human samples to guide targeted therapy.

TGA Public Summary